Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature.
|
18189029 |
2007 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Porphyria cutanea tarda (PCT) is the most common human porphyria, due to hepatic deficiency of uroporphyrinogen decarboxylase (UROD), which is acquired in the presence of iron overload and various susceptibility factors, such as alcohol abuse, smoking, hepatitis C virus (HCV) infection, HIV infection, iron overload with HFE gene mutations, use of estrogens, and UROD mutation.
|
30683557 |
2019 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda.
|
12622622 |
2003 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Hemochromatosis (HFE) gene mutations and hepatitis C virus infection as risk factors for porphyria cutanea tarda in Hungarian patients.
|
15101996 |
2004 |
Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
BEFREE |
HFE gene analysis should be done in patients who present with porphyria cutanea tarda.
|
15280838 |
2004 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Hemochromatosis gene (HFE) mutations and the hepatitis C virus (HCV) are known risk factors for porphyria cutanea tarda (PCT), but interactions with erythrocytic uroporphyrinogen decarboxylase (UROD) have seldom been addressed.
|
19001803 |
2009 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
HFE mutations also appear to increase the likelihood of iron overload in inherited anemias and to promote the clinical manifestations of porphyria cutanea tarda.
|
9727731 |
1998 |
Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
LHGDN |
Association of porphyria cutanea tarda with hereditary hemochromatosis.
|
15280838 |
2004 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda.
|
11069625 |
2000 |
Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
BEFREE |
Few studies have examined the connection between PCT and the regulation of iron metabolism genes other than the HFE gene.
|
29774528 |
2018 |
Porphyria Cutanea Tarda
|
0.600 |
Biomarker
|
disease |
LHGDN |
HFE gene in primary and secondary hepatic iron overload.
|
17729389 |
2007 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Inherited factors that may predispose to PCT include the C282Y mutation in the hemochromatosis (HFE) gene.
|
11499833 |
2001 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Inherited factors that, in combination, may predispose to PCT include mutations in the UROD gene, present in about 20% of patients, and the C282Y mutation in the haemochromatosis (HFE) gene.
|
9638727 |
1998 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Investigation of porphyria cutanea tarda association with C282Y and H63D mutations in the HFE gene.
|
24068123 |
2014 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the UROD and hemochromatosis (HFE) genes are genetic factors in some PCT patients which can be mimicked in mice heterozygous for the Hfe and Urod null genes.
|
20099833 |
2010 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our data do not confirm an association of PCT with the Cys282Tyr HFE mutation, strongly associated with hemochromatosis in Northern European countries.
|
9425935 |
1998 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Our results comprise the first molecular studies of both common and rare hemochromatosis gene variants in German PCT patients, indicating a significant role of the C282Y mutation in the pathogenesis of PCT.
|
17298224 |
2006 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
LHGDN |
Our results comprise the first molecular studies of both common and rare hemochromatosis gene variants in German PCT patients, indicating a significant role of the C282Y mutation in the pathogenesis of PCT.
|
17298224 |
2006 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Recent reports have described a significant association between inheritance of the C282Y and H63D mutations in the HFE gene, associated with genetic hemochromatosis (GH) and PCT.
|
12699243 |
2002 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Results of recent studies have demonstrated high prevalences (about 60%-80%) of HFE gene mutations in patients with porphyria cutanea tarda.
|
12957298 |
2003 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The HFE gene mutations were detected in 70% of patients with PCT compared with 35% in the control group (P < 0.001).
|
18565178 |
2008 |
Porphyria Cutanea Tarda
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The aims of this study were: 1) to assess the prevalence of HCV infection and HFE mutations in North American patients with PCT; 2) to compare demographic and laboratory features between those who are HCV-positive and HCV-negative; and 3) to study urinary porphyrin excretions in American HCV-positive patients without clinically manifest PCT.
|
9620340 |
1998 |